12.6.22, Pediatric Grand Rounds, " Transformative Treatment of Rare Disease - X-linked hypophosphatemia through the life span", Drs. Nancy Dunbar & Carolyn Macica

episode

Connecticut Children's Grand Rounds not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Pretty Little Episode #110 26 min · 25 Sep 2026 · Handsome

Ireland collapse in Kosovo as Israel game looms 13 min · 25 Sep 2026 · Today with David McCullagh

Living Breakthrough-Minded | Joel Osteen 30 min · 25 Sep 2026 · Joel Osteen Podcast

4AM ET 09/25/2026 Newscast 3 min · 25 Sep 2026 · Fox News Hourly Update

The Week: Trump vs the Press, Meta’s AI Win, and the Turning Political Tide 22 min · 25 Sep 2026 · The Prof G Pod with Scott Galloway

Gabrielle Lyon Part 2 1h 1m · 25 Sep 2026 · unPAUSED with Dr. Mary Claire Haver

Report any issue

Source

Recorded06 Dec 2022

Publisherfeeds.buzzsprout.com

Handlerec:1544876

Show notes

Relate the primary comorbid features of adult X-linked hypophosphatemia (XLH) to physical function.List and compare the Phase 3 Primary and Secondary endpoints for adults with XLH treated with Burosumab.Distinguish x-linked hypophosphatemic rickets from acquired forms of rickets such as vitamin D deficient rickets.Explain the mechanism of action of burosumab - a human recombinant anti-FGF-23 antibody therapy for X-linked hypophosphatemia.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in